期刊文献+

两种微刺激方法在IVF卵巢低反应患者中的应用

Application of two kinds of mild-stimulation methods in IVF of ovarian poor response patients
原文传递
导出
摘要 目的探讨两种微刺激方法在体外受精胚胎移植(IVF)卵巢低反应患者中助孕结局的比较。方法回顾性分析进行IVF/卵泡浆内单精子注射(ICSI)助孕的卵巢低反应患者共60个周期,根据用药情况分为两组:来曲唑组:共30个周期;克罗米芬组:共30个周期。分别比较两组患者的一般情况、促性腺激素(Gn)使用天数及总量、IVF相关指标及助孕结局。结果年龄、体质量指数、不孕年限、基础内分泌比较差异均无统计学意义(P〉0.05);克罗米芬组Gn天数及总量高于来曲唑组(P〈0.05);平均获卵数、受精率、卵裂率、着床率、临床妊娠率、流产率比较差异均无统计学意义(P〉0.05)。结论两种微刺激促排卵方案对于卵巢储备低下的患者均是有效的促排方案,来曲唑组可以获得与克罗米芬组相似的临床效果,同时减少Gn用量,减轻患者单周期的治疗费用。 Objective To investigate the comparison of assisted reproductive outcome of two kinds of mild-stimulation methods in IVF of ovarian poor response patients. Methods The ovarian poor response patients in IVF/ICSI with a total of 60 cycles was retrospectively analyzed. According to the difference of the ovarian stimuXation, the patients were divided into two groups : letrozole group : a total of 30 cycles and clomiphene citrate group : a total of 30 cycles. The general situation of the patients, Gn dosage and period, indicators associated with IVF lab and IVF outcome in the two groups were compared. Results Age, body mass index, infertility period, the basis of endocrine were not statistically different (P 〉 0.05) in the two groups; Gn doSage and treatment period in clomiphene citrate was higher than that in letrozole group (P 〈 0.05 ) ; Average numbers of oocytes retrieved, fertilization rate, cleavage rate, implantation rate, clinical pregnancy rate, abortion rate had no significant difference in the two groups (P 〉 0.05). Conclusions Two kinds of mild-stimulation methods for the ovarian poor response patients are both effective. Letrozole could reduce the Gn dosage and single cycle treatment costs and have the same pregnancy rate compared with clomiphene citrate.
出处 《中国实用医刊》 2013年第8期33-35,共3页 Chinese Journal of Practical Medicine
关键词 体外受精-胚胎移植 微刺激 卵巢低反应 克罗芬 来曲唑 In-vitro fertilization (IVF) Mild-stimulation Ovarian poor response Clomiphene Letrozole
  • 相关文献

参考文献5

二级参考文献59

  • 1钱云,刘嘉茵,冯婷,陈娟,蔡令波,冒韵东,丁卫,张燕.未成熟卵体外成熟技术在卵巢反应不良和卵泡发育迟缓周期中的应用[J].中国实用妇科与产科杂志,2005,21(4):217-219. 被引量:6
  • 2Watt AH, Legedza AT, Ginsburg ES et al. The prognostic value of age and follicle - stimulating hormone levels in women over forty years of age undwegoing in vitro fertilization. J Assist Reprod Genet, 2000,17 (5) : 264-268.
  • 3Lass A, Gerrard A, Abusheikha Net al. IVF performance ef women who have fluctuating early follicular FSH levels. J Assist Reprod Genet,2000, 17 (10): 566-573.
  • 4Hansen LM , Batzer FR , Gutmann JN et al. Evaluation ovarian reserve : Follicle stimulating hormone and estradiol variability during cycle days 2 -5. Hum Reprod , 1996, 11 (2) : 486-489.
  • 5Esposito MA, Coutifaris C & Barnhart KT. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. HumReprod, 2002, 17 (1) :118-123.
  • 6Smotrich D , Widra E , GindoffP et al. Prognostic value of day 3 estradiol on in vitro outcome. Fertil Steril , 1995 , 64 (6) : 1136-1140.
  • 7Welt CK, McNicholl DJ, Taylor AE et al. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab, 1999, 84 (1): 105-111.
  • 8Seifer DB, Lambert - Messerlian G, Hogan JW et al. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril, 1997, 67 ( 1 ) : 110 - 114.
  • 9De Vet A, Laven J. S , de Jong F. H et al. Anti - mullerian hormone serum levels: a putative marker for ovarian aging . Fertil Steril ,2002, 77 : 357-362.
  • 10Scott R, Hofmann G. Prognostic assessment of ovarian reserve. Fertil Steril, 1995, 63 (1): 1-11.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部